Sheila Krishnan

Physician, Pulmonary Hypertension, Lung Transplant at Corewell Health

[JHLT @TheJHLT]

Important new consensus statement from #ISHLT - A framework for evaluating and addressing #frailty throughout the #LungTx journey. 🫁

🔗: https://t.co/62ZjC9VWCg

[Sheila Krishnan @SheilaKrishnan2]

The Michigan Pulmonary Hypertension Symposium is a collaboration between Corewell Health, University of Michigan and Henry Ford. This is a CME-supported conference. To register visit https://t.co/lTkpNZYBYq.

[Andrea Nei @Dre_pharmd]

SCCM guideline on corticosteroid use in sepsis, ARDS, and CAP now available! Make sure to attend the Congress session Monday morning where @dipayan_c will present the panel recommendations! An incredible opportunity and a great panel to work with! @SCCM @CritCareMed @MayoPCCM

[Timothy Fernandes, MD, MPH @DrTimFernandes]

I had a great time at the @ICA_CTEPH Meeting this past weekend. Since I was the designated tweeter, here are highlights of my talk on Chronic Thromboembolic Pulmonary Disease w/o Pulmonary Hypertension. (What we in the 🇺🇸 call CTED...just rolls off the 👅easier) #CTEPH2023

[Sheila Krishnan @SheilaKrishnan2]

Reducing Pulmonary Capillary Wedge Pressure During Exercise Exacerbates Exertional Dyspnea in Patients With Heart Failure With Preserved Ejection Fraction - CHEST https://t.co/0s2mEMgyFG

[ATS Blue Journal @ATSBlueEditor]

Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study

🔗 https://t.co/fDLHsrVdvX

[Jason Weatherald MD @AlbertaPHdoc]

First results of #sotatercept from the open label extension #SOTERIA study. #ERSCongress #ERS2023
Stable improvements, few serious treatment emergent adverse events, maybe further improvement in low risk%
8 patients got off prostacyclin

[Mithu Maheswaranathan, MD @MithuRheum]

🆕 2023 ACR Guidelines for Management of Interstitial Lung Disease (#ILD) in Systemic Autoimmune Rheumatic Diseases 🫁

🔸 Screening & Monitoring Recs
🔸 Treatment Guidelines ILD/RP-ILD

#RheumTwitter #PulmTwitter #MedTwitter #MedX

[Jason Weatherald MD @AlbertaPHdoc]

Important new study on #CMR in #PulmonaryArterialHypertension out in @ERSpublications @ErsPvd. Which measures matter and what are the minimal clinically relevant changes for improvement and worsening?

https://t.co/MXvY22FRBW

[ERS publications @ERSpublications]

PAWP provides accurate but imprecise estimates for LVEDP during exercise. A combination of PAWP ≥25 mmHg at peak and/or PAWP/CO slope >2 mmHg/L/min correctly identify HFpEF patients among those individuals with either PAWP or LVEDP ≥25 mmHg at peak. https://t.co/3aUDPmofM0

[Jose A. Meade, MD @JoseMeadeMD]

🚨🚨RHEUM ALERT 🚨🚨🚨
Today is a big day for rheumatologists, vascular, and medicine in general!
New APS criteria finally out!

NO NEED FOR CLASSICAL THROMBOTIC EVENTS FOR CLASSIFYING.

Now other manifestations as DAH, adrenal hemorrhage & aPL antibodies are enough!!!

[Sarah Hudson @sarahhudsonuk]

Ten current papers for the curious general cardiologist, including semaglutide in HFpEF, IV iron in ambulatory HF pts, anticoagulation of atrial high rate episodes found on devices and new ESC guidelines

Sources: @CircAHA, @ESC_Journals, @JACCJournals, @NEJM

1/n

[NEJM @NEJM]

Late breaking at #ESCCongress: In patients with heart failure with preserved ejection fraction and obesity, semaglutide (2.4 mg) led to greater reductions in symptoms and physical limitations and greater improvements in exercise function than placebo. Full STEP-HFpEF trial:

[Massar @MassarOmard]

#SGLT2i's benefit in #HFpEF, but why and how?
First in HFpEF! SGLT2i's effect on #PCWP by #RHC in a mechanistic randomized trial. #Dapa⬇️PCWP, improving the fundamental hemodynamic abnormality underlying HFpEF. @CircAHA @MayoClinic @yreddyhf #Borlaugslab https://t.co/jIigjBXRAg

[JAMA @JAMA_current]

A new study builds on evidence that body mass index alone does not fully capture risk of death, @KateRuderWriter reports. https://t.co/kog7FRCDzS #MedicalNews

[NEJM @NEJM]

In patients with lung cancer, perioperative treatment with nivolumab + chemotherapy resulted in a higher percentage of patients with a pathological complete response and longer survival than chemotherapy alone. https://t.co/DCcs0tk10f

[Buitengebieden @buitengebieden]

Good boy stealing the show.. 😅

[Sarah Hudson @sarahhudsonuk]

Ten current papers for the curious general cardiologist, including troponin in stable CAD, coronary assessment in VT storm, balloon pulmonary angioplasty and CIED infections

Sources: @CircAHA, @ESC_Journals , @JACCJournals, @JAMACardio

1/n

[Mazen Al-Qadi @Mazen_Al_Qadi]

Very excited to share our paper!!!

[Baseball Quotes @BaseballQuotes1]

Brandon Crawford is a defensive wizard 🧙‍♂️